FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Tactile Systems Technology, Inc. Stock AnalysisComprehensive stock analysis for Tactile Systems Technology, Inc. (TCMD) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisTCMD
TCMD
Tactile Systems Technology, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
TCMD
Home🔹Stocks🔹Tactile Systems Technology, Inc.

Tactile Systems Technology, Inc.

TCMD•NASDAQ

Tactile Systems Technology, Inc.

TCMD•NASDAQ
Market cap
$625.71M
Sentiment

Your view on TCMD

Mkt Cap
$625.71M
Sentiment
Your view
TCMD
Tactile Systems Technology, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
TCMD
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Tactile Systems Technology, Inc.

Industry
Medical - Devices
Sector
Healthcare
CEO
Sheri Louise Dodd
Headquarters
3701 Wayzata Boulevard, Minneapolis, MN, US
Industry
Medical - Devices
Sector
Healthcare
CEO
Sheri Louise Dodd
Headquarters
3701 Wayzata Boulevard, Minneapolis, MN, US
Description

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News